The role of STATs in transcriptional control and their impact on cellular function - PubMed (original) (raw)
Review
. 2000 May 15;19(21):2468-73.
doi: 10.1038/sj.onc.1203476.
Affiliations
- PMID: 10851045
- DOI: 10.1038/sj.onc.1203476
Review
The role of STATs in transcriptional control and their impact on cellular function
J Bromberg et al. Oncogene. 2000.
Abstract
The STAT proteins (Signal Transducers and Activators of Transcription), were identified in the last decade as transcription factors which were critical in mediating virtually all cytokine driven signaling. These proteins are latent in the cytoplasm and become activated through tyrosine phosphorylation which typically occurs through cytokine receptor associated kinases (JAKs) or growth factor receptor tyrosine kinases. Recently a number of non-receptor tyrosine kinases (for example src and abl) have been found to cause STAT phosphorylation. Phosphorylated STATs form homo- or hetero-dimers, enter the nucleus and working coordinately with other transcriptional co-activators or transcription factors lead to increased transcriptional initiation. In normal cells and in animals, ligand dependent activation of the STATs is a transient process, lasting for several minutes to several hours. In contrast, in many cancerous cell lines and tumors, where growth factor dysregulation is frequently at the heart of cellular transformation, the STAT proteins (in particular Stats 1, 3 and 5) are persistently tyrosine phosphorylated or activated. The importance of STAT activation to growth control in experiments using anti-sense molecules or dominant negative STAT protein encoding constructs performed in cell lines or studies in animals lacking specific STATs strongly indicate that STATs play an important role in controlling cell cycle progression and apoptosis. Stat1 plays an important role in growth arrest, in promoting apoptosis and is implicated as a tumor suppressor; while Stats 3 and 5 are involved in promoting cell cycle progression and cellular transformation and preventing apoptosis. Many questions remain including: (1) a better understanding of how the STAT proteins through association with other factors increase transcription initiation; (2) a more complete definition of the sets of genes which are activated by different STATs and (3) how these sets of activated genes differ as a function of cell type. Finally, in the context of many cancers, where STATs are frequently persistently activated, an understanding of the mechanisms leading to their constitutive activation and defining the potential importance of persistent STAT activation in human tumorigenesis remains. Oncogene (2000).
Similar articles
- STAT proteins: from normal control of cellular events to tumorigenesis.
Calò V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. Calò V, et al. J Cell Physiol. 2003 Nov;197(2):157-68. doi: 10.1002/jcp.10364. J Cell Physiol. 2003. PMID: 14502555 Review. - Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner R, Mora LB, Jove R. Buettner R, et al. Clin Cancer Res. 2002 Apr;8(4):945-54. Clin Cancer Res. 2002. PMID: 11948098 Review. - STATs in oncogenesis.
Bowman T, Garcia R, Turkson J, Jove R. Bowman T, et al. Oncogene. 2000 May 15;19(21):2474-88. doi: 10.1038/sj.onc.1203527. Oncogene. 2000. PMID: 10851046 Review. - Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis.
Silva CM. Silva CM. Oncogene. 2004 Oct 18;23(48):8017-23. doi: 10.1038/sj.onc.1208159. Oncogene. 2004. PMID: 15489919 Review. - Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response.
Korpelainen EI, Kärkkäinen M, Gunji Y, Vikkula M, Alitalo K. Korpelainen EI, et al. Oncogene. 1999 Jan 7;18(1):1-8. doi: 10.1038/sj.onc.1202288. Oncogene. 1999. PMID: 9926914
Cited by
- Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling.
Shi C, Bopp T, Lo HW, Tkaczuk K, Lin J. Shi C, et al. Curr Oncol. 2024 Sep 25;31(10):5737-5751. doi: 10.3390/curroncol31100426. Curr Oncol. 2024. PMID: 39451730 Free PMC article. Review. - Model systems and clinical applications of hepatic stem cells for liver regeneration.
Zhang M, Zhong Y, Chen J. Zhang M, et al. Hepatol Int. 2012 Jun;6(3):564-75. doi: 10.1007/s12072-011-9323-6. Epub 2011 Dec 21. Hepatol Int. 2012. PMID: 26201471 - A Resveratrol Analogue Promotes ERKMAPK-Dependent Stat3 Serine and Tyrosine Phosphorylation Alterations and Antitumor Effects In Vitro against Human Tumor Cells.
Chelsky ZL, Yue P, Kondratyuk TP, Paladino D, Pezzuto JM, Cushman M, Turkson J. Chelsky ZL, et al. Mol Pharmacol. 2015 Sep;88(3):524-33. doi: 10.1124/mol.115.099093. Epub 2015 Jul 2. Mol Pharmacol. 2015. PMID: 26138072 Free PMC article. - The efficiency of silencing expression of the gene coding STAT3 transcriptional factor and susceptibility of bladder cancer cells to apoptosis.
Bednarek I, Sypniewski D, Gawlik N, Galilejczyk A, Goraus K. Bednarek I, et al. Contemp Oncol (Pozn). 2012;16(4):316-21. doi: 10.5114/wo.2012.30060. Epub 2012 Sep 29. Contemp Oncol (Pozn). 2012. PMID: 23788901 Free PMC article. - The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L, Barroso E, El Kochairi I, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M. Serrano-Marco L, et al. Diabetologia. 2012 Mar;55(3):743-51. doi: 10.1007/s00125-011-2401-4. Epub 2011 Dec 17. Diabetologia. 2012. PMID: 22179221
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous